Phylogenetic analysis of E. coli causing bacteraemia in the UK and Ireland in 2001 and 2010 Williams, MJ.*, Doumith, M.*, Hope, R.*, Wain, J.*, Underwood,

Slides:



Advertisements
Similar presentations
Resistant Gram-negative Infections 21 st March 2013 Acute Medicine Study Day Dr Sarah Glover Consultant in Medical Microbiology and Infectious Diseases.
Advertisements

BSAC ANTIMICROBIAL SUSCEPTIBILITY TESTING & RESISTANCE MEETING CARDIFF – 13 TH MAY, 2010 Vancomycin Susceptibility Testing in Staphylococcus aureus: Clinical.
Antibiotic treatment choices for SBP Treviso 8 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Increasing transrectal ultrasound guided prostate biopsy associated infection; is a change in antimicrobial prophylaxis the solution? Authors: Ni Bhuachalla.
The Use of Cefoxitin for the Determination of Methicillin Resistance in Staphylococci John D. Perry Microbiology Department Freeman Hospital Newcastle.
Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
National and International Spread of Antimicrobial Resistance: Clones and Genes Professor Alan Johnson, Health Protection Services - HPA.
+ Clonal expansion of ciprofloxacin-resistant Campylobacter jejuni Jasna Kova č, Alison J. Cody, James E. Bray, Kate E. Dingle, Sonja Smole Mo ž ina, Martin.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Panton-Valentine Leukocidin (PVL) is a toxin that destroys white blood cells and is a virulence factor in some strains of Staphylococcus aureus. PVL occurs.
Predicting multi-drug resistance in Pseudomonas aeruginosa in the UK and Ireland Rosy Reynolds, Russell Hope, Kirsty Maher on behalf of The BSAC Working.
Typhoid Fever in Africa: Emerging Flouroquinolone Resistance S KARIUKI 1,3, G REVATHI 2, J MUYODI 1, J MWITURIA 1, A MUNYALO 1, S MIRZA 3, CA HART 3 1.
Trends in S. aureus bacteremia : England compared with its Celtic neighbors Rosy Reynolds, Russell Hope on behalf of the BSAC Working Party on.
Resistance in Pseudomonas aeruginosa and Acinetobacter spp. from blood in the UK and Ireland Rosy Reynolds, Russell Hope, BSAC Working Party.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
The role of the English Surveillance Programme on Antimicrobial Use & Resistance in improving stewardship Susan Hopkins Consultant Infectious Diseases.
Veterinary Type Cultures Collection,
Susceptibility Patterns over 3 years in Community-acquired Lower Respiratory Infection in the UK and Ireland R. Reynolds, D. Felmingham BSAC Working Party.
To enhance students ability to interpret data in charts and graphs To discuss basic concepts in epidemiology and science.
Resistance in agents of hospital-acquired respiratory infection in the UK and Ireland 2008/09 Rosy Reynolds, Ian Morrissey, Russell Hope on behalf of the.
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
22 February 2016 GRASP (Gonococcal Resistance to Antimicrobials Surveillance Programme) Catherine Ison Sexually Transmitted Bacteria Reference Laboratory.
Mupirocin Resistance in Staphylococci After Three Years of Universal MRSA Admission Screening Rosy Reynolds, Shazad Mushtaq, Angela Kidney on behalf of.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
Prof KN Prasad, MD Department of Microbiology,
Listeria monocytogenes serovar prevalence and dominance dynamics in meat products: A useful insight into the underrepresentation of serovar 4b strains.
Materials & Methods Objective Extraintestinal pathogenic Escherichia coli in healthy broiler chicken in Italy: a combination of virulence with antibiotic.
Characterization of B-lactam resistance mechanisms among UTI isolates collected from women attending primary care across Europe- RGNOSIS P th ECCMID.
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
D. Sauerwein  International Journal of Antimicrobial Agents 
Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China  Y. Chen,
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis isolates from poultry farms in Tunisia Guedda Intissar1, Abbassi Mohamed Salah1,
Figure 1 Principle coordinates analysis plot for 127 Escherichia coli isolates from the SENTRY and Meropenem Yearly Susceptibility Test Information Collection.
Introduction and Purpose References and Acknowledgements
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
Average susceptibility
Antibiotic Susceptibility patterns of culture-positive urine isolates in children under 14 years. Paul Ombuya Laboratory technologist At GCH October 2013.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Disc susceptibility testing for Burkholderia cepacia complex
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Prevalence of CTX-M-14 type in Welsh Hospitals
Molecular characterisation of
To screen or not to screen for VRE in immunocompromised patients?
BSAC Bacteraemia Resistance Surveillance Update 2013
Neisseria gonorrhoeae: the first untreatable infection
Norwegian patients and retail chicken meat share cephalosporin-resistant Escherichia coli and IncK/blaCMY-2 resistance plasmids  E.S. Berg, A.L. Wester,
L. Moles, M. Gómez, E. Jiménez, L. Fernández, G. Bustos, F. Chaves, R
The need for new antibiotics
Zhangqi Shen, Yang Wang, Yingbo Shen, Jianzhong Shen, Congming Wu 
Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the Diversi-Lab repetitive sequence-based PCR system 
Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy  M. Cerquetti, M. Giufrè, A. García-Fernández,
Phylogenetic tree of perA A2-domain DNA sequence.
Figure 1. Colistin MIC distribution for the 153 colistin-resistant E
Antibiotic resistance: location, location, location
Stabilization in prevalence of ESBLs & ciprofloxacin non-susceptibility in Enterobacteriaceae from blood in the UK and Ireland Rosy Reynolds, Russell.
Figure 1. SpeI-PFGE dendrogram comparing P
M. J. Medina-Pascual, S. Valdezate, G. Carrasco, P. Villalón, N
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
7th East African Health & Scientific Conference
Phylogenetic tree of intestinal pathogenic E. coli.
EARS-Net results 2011 Ole Heuer
Multiplex PCR assay to detect common resistance determinants in B
Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China  Y. Chen,
Presentation transcript:

Phylogenetic analysis of E. coli causing bacteraemia in the UK and Ireland in 2001 and 2010 Williams, MJ.*, Doumith, M.*, Hope, R.*, Wain, J.*, Underwood, A.*, Turton, J.*, Reynolds, R. #, Livermore, DM.* and Woodford, N.* *HPA Colindale, London, UK, # BSAC, Bristol, UK Introduction E.coli is one of the commonest agents of bacteraemia, gastrointestinal and urinary tract infections (UTIs) in the UK. While E. coli lineages causing UTIs and gastrointestinal disease are well known, less is known about those from bacteraemias. We compared the phylogeny of E. coli from bacteraemias in the UK and Ireland in 2001 vs Methods 409 E.coli isolates from 18 centres across the UK and Ireland from the BSAC Bacteraemia Surveillance Programme from from 2010 Assigned to phylogroups (A, B1, B2 or D) by PCR using a modified method 2 based on the Clermont 3 scheme Multi-locus sequence typing was used to analyse 152 isolates from 2001 and 116 isolates from 2010 using the Achtman scheme 4 Resistance testing performed by agar dilution 5 ESBL presence confirmed by PCR 5 Conclusions Phylogroups B2 and D dominated in both years; these harbour virulence factors associated with extra-intestinal E. coli 8 With the exception of ST131, the major STs in both years remained susceptible to most antimicrobials The major STs have been reported to be associated with UTIs 9 There was a significant increase in cases of bacteraemia caused by the international ST131 clone, with more members of this clone found resistant in 2010 than Resistance to cephalosporins, aminoglycosides and quinolones rose from 2001 to 2010 largely due to diverse STs and ST131 Carbapenem resistance was not seen References Doumith M., Williams M.J. and Woodford N. unpublished, 3 Clermont O, Bonacorsi S, Bingen E. Appl Environ Microbiol Oct;66(10): Lau et al. J Clin Microbiol March; 46(3): 1076– Jakobsen et al. Foodborne Pathog Dis May;7(5): Picard et al. Infect Immun Feb;67(2): Croxall et al. J Antimicrob Chemother Nov;66(11): Pathog Dis.Infect Immun.J Antimicrob Chemother. Figure 2. Percentage phylogroups by year Results 1.MLST A total of 83 STs were detected (see figure 1a) of which: 47 were only present in were only present in were present in both years ST73 was the most common ST in both years (20% of isolates in 2001 and 22% in 2010); it is also as a major ST in UTIs 6 42% of isolates in 2001, 59% in 2010 belonged to ST73, ST95, ST131, ST12 and ST127 Prevalent STs were distributed across multiple centres in both years (figure 1b) Figure 4. Sources of bacteraemia by year and ST Year 2.Phylotyping The phylogroup distributions of the 2001 and 2010 isolates were similar, and resembled those reported for UTI isolates 7, with B2 dominant (77% in 2001; 71% in 2010) (figure 2) Second most common was phylogroup D (11% 2001 and 14% 2010), followed by group B1 (6% vs 8%) then A (4% vs 6%) ST/Year Percentage 3. Antimicrobial resistance and bacteraemia origins UTIs were the commonest source of bacteraemias (figure 4) including those due to the 5 major STs (except ST127 in 2010, where many bacteraemias had unknown sources) There was a significant increase of resistance to gentamicin, ciprofloxacin and cephalosporins in 2010 mainly due to diverse ST types and ST131 Amoxicillin resistance remained unchanged in both years (56%) Numbers of isolates belonging to the international ST131 clone rose from 5/152 in 2001 (4 centres) to 16/116 in 2010 (10 centres) None of the ST131 isolates in 2001 was ciprofloxacin-resistant or ESBL-positive, but 11 were ciprofloxacin-resistant in 2010 and 5 (from multiple centres) had ESBLs. (see table 1) Figure 1. Minimum spanning trees showing ST distribution by; 1a) year 152 isolates from 2001 (white) 116 isolates from 2010 (black) 1b) centre 268 isolates coloured by centre ST69 ST127 ST393 ST73 ST131 ST12 ST95 ST117 ST415 ST59 ST357 ST80 ST14 ST404 ST10 ST88 ST73 ST127 ST131 ST12 ST95 Table 1. Prevalence of resistance Percentage of resistant isolates in 2001vs 2010 in all STs, major STs (ST73, ST95, ST131, ST12 and ST127) and in other non-major STs. *Resistance in ST131 only #Resistance in ST131 and 1 isolate of ST12 Percentage